What Does a Thickened Endometrial Stripe Mean?

A thickened endometrial stripe on an ultrasound report means the lining of the uterus measures thicker than expected for your age, menstrual phase, or menopausal status. In most cases it reflects something benign, such as a polyp, a normal hormonal fluctuation, or the effect of a medication. But because a thicker-than-expected lining can occasionally signal hyperplasia or endometrial cancer, the finding usually prompts your doctor to figure out why it’s thick rather than assume the worst.

What the Endometrial Stripe Actually Measures

During a transvaginal ultrasound, the sonographer places the probe so it captures a lengthwise view of the uterus. The endometrial stripe is the bright line running down the center, representing both layers of the uterine lining pressed together. The measurement is taken at the thickest point, in millimeters. In premenopausal women, this number shifts constantly with the menstrual cycle: it’s thinnest right after a period (sometimes just 1–4 mm), grows through the first half of the cycle, and peaks around ovulation or shortly after, sometimes reaching 12–16 mm before shedding again. That normal fluctuation is one reason the number on your report can look alarming if you don’t know where you were in your cycle when the scan was done.1PubMed Central. Thickened Endometrium: When to Intervene? A Clinical Conundrum

After menopause, when estrogen levels drop and monthly cycles stop, the lining thins out. Doctors generally consider anything at or below about 4–5 mm to be within the expected range for a postmenopausal woman who is not on hormone therapy. When the stripe measures above that threshold, it doesn’t automatically mean something is wrong, but it does narrow the list of possible explanations and sometimes triggers further testing.

Benign Causes That Make the Lining Look Thick

Polyps are probably the single most common structural cause of a thickened endometrial stripe, especially in postmenopausal women. One study found that polyps accounted for over half of cases of endometrial thickening in postmenopausal women without bleeding symptoms.2PubMed Central. Association of endometrial thickness with lesions in postmenopausal asymptomatic women: risk factors and diagnostic thresholds Polyps are fleshy growths that project into the uterine cavity; they’re almost always noncancerous, though a small percentage can harbor precancerous or cancerous cells. On a standard ultrasound, a polyp can make the entire stripe measurement look uniformly thick, which is why additional imaging is often needed to tell a polyp apart from diffuse thickening.

Submucosal fibroids, which are benign muscular growths that bulge into the uterine cavity, create a similar problem. They push into the endometrial layer and inflate the stripe measurement. A study of premenopausal women with stripe measurements under 5 mm still found polyps in about 14% and submucosal fibroids in about 6%, which tells you that focal growths can exist even when the overall number looks reassuring.3Obstetrics & Gynecology. Detection of Benign Endometrial Masses by Endometrial Stripe Measurement in Premenopausal Women In other words, the stripe measurement is a useful screening tool, but it’s not perfect at catching every focal lesion.

Saline-infused sonohysterography, where sterile saline is gently pushed into the uterine cavity during the ultrasound, helps outline polyps and fibroids that a standard scan might miss. The fluid separates the walls of the uterus so individual growths become much easier to see.4PubMed. Through thick and thin: a pictorial review of the endometrium

Hormonal Reasons for a Thicker Lining

Estrogen is the main hormone that stimulates the endometrial lining to grow. Any condition that raises estrogen levels, or leaves the lining exposed to estrogen without enough progesterone to counterbalance it, can cause the stripe to be thicker than expected.

Polycystic ovary syndrome is a classic example. Women with PCOS often don’t ovulate regularly, which means they produce estrogen but not the progesterone surge that normally follows ovulation. One study found that the average endometrial thickness in women with PCOS was about 11 mm, compared with roughly 6 mm in a control group without the condition.5PubMed. Polycystic ovarian syndrome, insulin resistance and thickness of the endometrium That persistent, unopposed estrogen exposure is also why women with PCOS carry a higher long-term risk of endometrial hyperplasia.

Obesity works through a related pathway. Fat tissue produces its own estrogen by converting other hormones, and obesity-driven insulin resistance compounds the effect by reducing levels of the protein that normally binds up circulating estrogen and keeps it in check.6PubMed Central. Correlation of Metabolic Factors with Endometrial Atypical Hyperplasia and Endometrial Cancer: Development and Assessment of a New Predictive Nomogram Being overweight is, in fact, one of the strongest risk factors for both endometrial thickening and endometrial cancer.

Medications That Affect the Endometrial Stripe

If you’re taking tamoxifen for breast cancer prevention or treatment, a thickened endometrial stripe is a well-known side effect that frequently puzzles both patients and clinicians. Tamoxifen blocks estrogen in breast tissue but has a stimulatory effect on the uterine lining. In a study of tamoxifen-treated women, nearly half had stripe measurements of 8 mm or more. Among those women, biopsies turned up a mix of polyps, hyperplasia, and a small number of cancers, but also many normal results.7PubMed. Endometrial thickness in tamoxifen-treated patients: correlation with clinical and pathologic findings The difficulty is that tamoxifen also changes the texture of the endometrium in ways that make ultrasound readings unreliable, so a thick-looking stripe in a tamoxifen user doesn’t carry the same predictive weight it would in someone not on the drug. Most guidelines recommend investigating further only if bleeding develops, rather than reacting to the number alone.

Hormone replacement therapy is another common medication-related cause. Women on sequential HRT, where estrogen is taken continuously and a progestogen is added for part of each month, tend to have thicker endometrial stripes than women not on hormones. One study found an average measurement of about 8 mm in HRT users versus 5 mm in controls, with the lining peaking during the estrogen-dominant phase of the cycle.8PubMed. Change in endometrial thickness in postmenopausal women undergoing hormone replacement therapy Measurements in women on estrogen replacement can range anywhere from 1 to 15 mm depending on the regimen and timing.9American Journal of Obstetrics and Gynecology. Transvaginal ultrasonographic measurement of endometrial thickness in postmenopausal women receiving estrogen replacement therapy

The progestogen component matters enormously here. About one in five women given estrogen alone for a year develop endometrial hyperplasia, and the risk of endometrial cancer is roughly two to three times higher with unopposed estrogen. Adding progestogen dramatically reduces that risk, though sequential regimens don’t eliminate it entirely.10PubMed. Hormone replacement therapy and the endometrium This is why your doctor will want to know exactly what HRT formulation you’re on before interpreting a stripe measurement.

When Thickening Points to Hyperplasia

Endometrial hyperplasia is a condition where the lining cells multiply more than they should, producing an overgrown, thickened endometrium. It’s not cancer, but certain types carry a meaningful risk of becoming cancer. The key distinction is whether the overgrown cells look abnormal under a microscope. Simple hyperplasia without abnormal-looking cells rarely progresses to cancer. Atypical hyperplasia, where the cells do look abnormal, carries a much higher risk, estimated at somewhere between 20% and 50% depending on the specific features and genetic factors involved.11PubMed Central. Endometrial Atypical Hyperplasia and Risk of Endometrial Cancer

Two classification systems exist for grading hyperplasia, and they emphasize slightly different features. The more traditional system focuses on whether cytological atypia is present and tends to be more specific for high-risk lesions. A newer system looks at a broader combination of structural features and is considered more sensitive, meaning it catches more cases that need treatment but may also flag some that would have been fine left alone.12PubMed. Endometrial hyperplasia and the risk of coexistent cancer: WHO versus EIN criteria For you as a patient, the practical takeaway is that if a biopsy shows hyperplasia, your doctor will look closely at whether atypia is present, because that determines the urgency and type of treatment.

Endometrial Cancer and the Limits of the 4–5 mm Cutoff

The reason a thickened stripe gets attention is the association with endometrial cancer. In postmenopausal women who are bleeding, the widely used 5 mm cutoff has strong negative predictive value: if the stripe is at or below 5 mm, the chance of cancer drops to less than 0.1%.13PubMed. How thick is too thick? When endometrial thickness should prompt biopsy in postmenopausal women without vaginal bleeding That statistic, however, applies specifically to women who are symptomatic with bleeding. And not all types of endometrial cancer play by these rules.

Uterine serous carcinoma, an aggressive subtype, is particularly tricky. A study of women with confirmed serous carcinoma found that nearly a quarter had stripe measurements of 4 mm or less at diagnosis.14PubMed. Ultrasonographic evaluation of endometrial stripe thickness is insufficient to rule out uterine serous carcinoma This aggressive cancer type can arise from a thin, atrophic lining rather than a thick one, which is why relying solely on stripe thickness as a safety net has real limitations. A recent study echoed this concern, finding that type 2 (more aggressive) endometrial cancers were associated with a higher proportion of measurements at or below 4 mm compared with the more common type 1 cancers.15Reproductive, Female and Child Health. Revisiting the 4 mm Endometrial Stripe Thickness Threshold for Risk Stratification of Endometrial Cancer

Endometrial cancer more commonly appears as diffuse thickening throughout the cavity, though early-stage cases can sometimes look like a focal polyp-like mass.16PubMed. Sonohysterographic findings of endometrial and subendometrial conditions This is part of why biopsy remains the gold standard: ultrasound can tell you something looks thick or irregular, but only a tissue sample can say definitively what’s going on at the cellular level.

When Thickening Is Found Without Any Symptoms

Increasingly, a thickened endometrial stripe shows up as an incidental finding on a scan done for an entirely different reason, like checking for ovarian cysts or evaluating pelvic pain. The question of what to do when there are no symptoms, particularly no bleeding, is genuinely debated in the field.

Current guidance suggests that a postmenopausal woman without bleeding, without risk factors for endometrial cancer, and with a uniformly thickened stripe below about 11 mm generally does not need an invasive workup. Above 11 mm, or if the ultrasound shows worrisome features like irregular texture, unusual blood flow patterns, or fluid with debris, further investigation is warranted even without symptoms.17Journal of Obstetrics and Gynaecology Canada. Asymptomatic Endometrial Thickening Risk factors such as obesity, late menopause, use of unopposed estrogen, and a family history of certain cancers lower that threshold and may tip the balance toward a biopsy even at more modest measurements.

One study looking specifically at asymptomatic postmenopausal women identified a diagnostic threshold of about 5.65 mm as the point where the ultrasound measurement best balanced sensitivity and specificity for detecting significant lesions. In that same study, being overweight emerged as an independent risk factor for having a thickened lining after menopause.2PubMed Central. Association of endometrial thickness with lesions in postmenopausal asymptomatic women: risk factors and diagnostic thresholds

How Doctors Investigate a Thickened Stripe

The workup typically follows a step-by-step approach depending on symptoms, age, and how thick the measurement is.

One limitation of office biopsy worth knowing about is that the Pipelle samples blindly. It scrapes a strip of tissue but can miss focal lesions like small polyps. If your biopsy comes back as “insufficient tissue” or “benign” but your symptoms continue or the ultrasound still looks abnormal, further investigation with hysteroscopy is usually the next move.

Treating Endometrial Hyperplasia

When a biopsy confirms hyperplasia, treatment depends on whether atypia is present. Simple hyperplasia without atypia is often managed with progestogen therapy, which counteracts the estrogen-driven overgrowth and prompts the lining to shed and reset. This can be given as oral tablets, but a progesterone-releasing intrauterine device has emerged as the more effective option.

A Cochrane review of ten randomized trials found that the intrauterine device achieved regression of hyperplasia in roughly 85–92% of cases within six months, compared with about 72% for oral or injected progestogens.21Cochrane Database of Systematic Reviews. Intrauterine progesterone-releasing system for treatment of endometrial hyperplasia A separate meta-analysis reported even starker numbers: a resolution rate above 91% with the device versus under 69% with systemic progestins, and the device group also had lower rates of eventually needing a hysterectomy.22Journal of Gynecology Obstetrics and Human Reproduction. Levonorgestrel-releasing intrauterine system versus systemic progestins in management of endometrial hyperplasia

For atypical hyperplasia, the conversation shifts. Because the risk of progression to cancer is substantial, hysterectomy is often recommended for women who have completed childbearing. Women who wish to preserve fertility may still be offered progestogen therapy with very close monitoring, including repeat biopsies every three to six months, but this is a higher-stakes decision that involves weighing cancer risk against reproductive goals.

Cesarean Scars and Misleading Measurements

A less well-known source of confusing ultrasound findings is the cesarean section scar defect, sometimes called an isthmocele or uterine niche. This is a small pouch or indentation in the uterine wall at the site of a prior cesarean incision. Blood can pool in this niche, and the adjacent lining may appear irregular or thickened on ultrasound, mimicking a more worrisome finding. An isthmocele can also cause prolonged spotting after periods and pelvic pain, symptoms that might prompt an ultrasound in the first place. As cesarean rates have risen worldwide, this entity has become more commonly recognized, and it’s worth mentioning to your doctor if you’ve had a prior cesarean and your endometrial stripe looks unusual on a scan.23PubMed Central. Uterine Isthmocele-A Frequently Overlooked Complication of Cesarean Sections

Why Context Matters More Than the Number

The endometrial stripe measurement is genuinely useful, but it is a screening tool, not a diagnosis. The same number can mean very different things depending on whether you are 30 or 65, whether you are on day 5 or day 21 of your cycle, whether you take tamoxifen or HRT, and whether you have symptoms like bleeding. A reading of 10 mm in a 28-year-old in the luteal phase of her cycle is perfectly normal. A reading of 10 mm in a 70-year-old with postmenopausal bleeding is something that needs a biopsy promptly.

If your ultrasound report flags a thickened endometrial stripe, the most productive thing you can do is make sure your doctor knows the full picture: your menopausal status, the date of your last period if applicable, every medication you take, and whether you’ve had any bleeding or spotting. That context determines whether the finding warrants immediate workup, a repeat scan timed to a different point in your cycle, or simply a note in your chart for follow-up down the road.